Patents
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
10/2008
10/30/2008US20080269228 Hydrazide-containing hepatitis c serine protease inhibitors
10/30/2008US20080269221 Antibacterial agents
10/30/2008US20080267918 Serine protease inhibitors; replication inhibition
10/30/2008US20080267813 Corrosion inhibitor for protecting metallic materials in strongly alkaline medium
10/29/2008EP1984344A2 Multicyclic amino acid derivatives and methods of their use
10/29/2008CN101296917A Preparation of cyclic, ketalized ketones by favorskii rearrangement and the use thereof for the preparation of glucokinase activator 70
10/29/2008CN101296914A Derivative having PPAR agonistic activity
10/29/2008CN101296910A Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase
10/29/2008CN101296909A Pyrazine derivatives and use as pI3K inhibitors
10/29/2008CN101296908A Tricyclo substituted amides as glucokinase modulators
10/29/2008CN101296897A PPAR modulating biaromatic compounds
10/29/2008CN101293869A Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p561lck tyrosine kinases
10/28/2008USRE40558 Peroxisome proliferator-activated receptors agonists/ antagonists; 2-methyl-6-[3-(quinolin-2-ylmethoxy)-propoxymethyl]-benzoic acid; eating diorders; physiological detrimental blood level of insulin, glucose, free fatty acids, or triglycerides; hyperlipemia; atherosclerosis; antidiabetic agent
10/28/2008US7442704 Amide derivatives
10/28/2008US7442702 Prostaglandin agonists
10/28/2008US7442447 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes
10/28/2008CA2300319C 4-cyano-4-deformylsordaricin derivatives
10/23/2008WO2008125342A2 Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals
10/23/2008WO2008090357A3 N, n; -substituted piperazines binding to melanocortin receptor
10/23/2008US20080262230 Tachykinin receptor anatgonist; good transfer into blood; long half-life; stability; bradycardial agents; antiinflammatory agents ; antallergens; analgesics; antiemetics; irritable bowel disorders; skin disorders; antidepressants; antiischemic agents ; anxiolytic agents; autoimmune diseases; muscle relax
10/23/2008US20080262229 Analgesics; pain management
10/23/2008US20080261994 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis
10/23/2008US20080261989 Quinoxaline Inhibitors of the Hedgehog Signalling
10/23/2008US20080261985 treating a disorder characterized by the overexpression of iNOS or COX-2 genes; rheumatoid arthritis, inflammatory bowel disease, lupus, multiple sclerosis, or psoriasis; cancer
10/23/2008US20080261978 treating or preventing HIV infections, and in treating proliferative disorders such as inhibiting the metastasis of various cancers; 1-(4-((pyridin-2-ylmethylamino)methyl)benzyl)-3-phenylurea
10/23/2008US20080261966 Bis-aryl sulfonamides
10/23/2008DE102007018149A1 Substituted compound for producing pharmaceuticals for treating or prophylaxis of pain, nerve injuries, respiratory disorder, has general formulae
10/23/2008CA2683461A1 Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals
10/22/2008EP1660461B1 Novel condensed n-pyrazinyl-sulphonamides and their use in the treatment of chemokine mediated diseases
10/22/2008CN100427482C N,N-dimethylaminoacyl-2,3-difuryl-6-aminoquinoxaline, preparation method and application thereof
10/22/2008CN100427474C Method of preparing 3-methylquinoxaline-2-carboxylic acid
10/22/2008CN100427473C Synthesis method of key intermediate 2-cyanpyrazine of tuberculosis drug pyrazinamide
10/21/2008US7439362 For treatment of acne, seborrhea, androgenic alopecia. hirsutism, and breast cancer
10/21/2008US7439358 Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
10/21/2008CA2368823C Use of dopamine d3 receptor ligands for producing medicaments for treating kidney disorders
10/21/2008CA2296732C Polyhydroxyalkylpyrazine derivatives, their preparation and medicines containing them
10/16/2008WO2008123207A1 Ornithine derivative
10/16/2008WO2008122504A1 Alpha-hydroxyketones
10/16/2008WO2008122329A1 Uv-filter compounds
10/16/2008WO2008106479A3 Poly(1,4-piperazin-2-ones) as rod-like protein- protein interaction inhibitors and their production
10/16/2008WO2008057862A3 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-ϰB ACTIVITY AND USE THEREOF
10/16/2008US20080255360 reacting ethanolamine with ammonia in the presence of a heterogeneous transition metal catalyst and hydrogen, to form a reaction product selected from ethylenediamine, diethylenetriamine, aminoethylethanolamine, piperazine, N-(2-aminoethyl)piperazine, triethylenetetramine and/or mixtures
10/16/2008US20080255346 Ratiometric fluorescent chemosensor for selective detection of Hg (II) ions
10/16/2008US20080255345 IRNA Agents Targeting CCR5 Expressing Cells And Uses Thereof
10/16/2008US20080255221 Novel hydroxamates as therapeutic agents
10/16/2008US20080255214 Novel hydroxamates as therapeutic agents
10/16/2008US20080255152 Diaryl ethers as opioid receptor antagonists
10/16/2008US20080255151 N-deacetylthiocolchicine deriatives, their use and pharmaceutical formulations containing them
10/16/2008US20080255150 2-[(1-Piperazinyl)methyl]phenylacetic acid derivatives such as 3-(4-chloro-2-{[(3S)-3-methyl-4-(phenylacetyl)piperazin-1-yl]methyl}phenyl)propanoic acid; antihistamines, bronchodilator agents; asthma, rhinitis; treating prostaglandin D2 mediated disease
10/16/2008US20080255149 1-Oxopiperidine derivatives; amides derived from fused and/or spiro polyheterocycles such as decahydro-(iso)quinoline, tetrahydro(iso)quinoline, piperazine, piperidine, indole, or (iso)indole; histone deacetylase inhibitors; antiproliferative, antitumor, and antitumor agents; hyperplasia; immune diseases
10/16/2008US20080255144 (3'-Chloro-4-methanesulfonyl-biphenyl-2-yl)-[4-(3,4-dichloro-phenyl)-piperazin-1-yl]-methanone; neurological and neuropsychiatric disorders including schizophrenia
10/16/2008US20080255137 N-Biaryl and N-Arylheteroaryl 2-Substituted Piperazine Derivatives as Modulators of the 5ht2c Receptor Useful for the Treatment of Disorders Related Thereto
10/16/2008US20080255130 Bicyclic Nitrogen-containing Heterocyclic compounds for use as Stearoyl CoA Desaturase inhibitors
10/16/2008US20080255129 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics
10/16/2008US20080255109 Antigonadotrophins; breast and prostate cancer, endometriosis, benign prostate hyperplasia; regulation of fertility; 4-(3-Chloro-4-{{(4-chloro-benzenesulfonyl)-methyl-amino]-methyl}-thiophene-2-carbonyl)-3,4-dihydro-2H-benzo[1,4]oxazine-2carboxylic acid (3-methyl-[1,2,4]oxadiazol-5-ylmethyl)-amide
10/16/2008US20080255102 1-(2,3-dihydro-4H-1,4-benzoxazin-4-yl)-3-(methylamino)-1-phenylpropan-2-ol; fluctuations of sex steroid lelels; monoamine reuptake modulator; antidepressant, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue and fibromylagia syndrome, stress and urinary incontinence
10/16/2008CA2682304A1 Microbial reduction of an acetoxyketone
10/16/2008CA2681861A1 Ornithine derivative
10/15/2008EP1979322A1 Cyclohexyl sulfonamide derivatives having h3 receptor activity
10/15/2008EP1979320A2 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS
10/15/2008CN101284865A New compound and its medicine use
10/15/2008CN100425596C Process for preparing deoxy fructosazine
10/14/2008US7435735 Hydroxy pyridopyrrolopyrazine dione compounds useful as HIV integrase inhibitors
10/09/2008WO2007149478A3 Pyrazine derivatives with extended conjugation and uses thereof
10/09/2008US20080249307 reacting 1,2-dichloroethane with ammonia to form a reaction product comprising ethylenediamine, diethylenetriamine, piperazine, triethylenetetramine, tetraethylenepentamine, pentaethylenehexamine and/or mixtures and hydrogen chloride
10/09/2008US20080249139 N-((1S,2R)-1-(3,5-difluorobenzyl)-3-{[(1S)-7-ethyl-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-2-hydroxypropyl)pyrazine-2-carboxamide for example; or corresponding sulfonamides; beta-secretase inhibitors; dementia; Alzheimer's disease
10/09/2008US20080249108 treatment of sleep disorders or inflammatory diseases of the bladder by administering N-benzyl-2-phenylpiperazine-1-carboxamides, e.g., 2-(S)-(4-Fluoro-2-methyl-phenyl)-piperazine-1-carboxylic acid [1-(R)-(3,5-bis-trifluoromethyl-phenyl)-ethyl]-methyl-amide methansulfonate
10/09/2008US20080249107 Comprising trihydroxy phenyl subunits; selectin inhibitors; side effect reduction; 3-{3-[3-(3,4,5-Trihydroxy-phenyl)-propionylamino]-phenylamino}-benzoic acid
10/09/2008US20080249102 Hiv Protease Inhibitors
10/09/2008US20080249101 BENZOIMIDAZOLE, TETRAHYDRO-QUINOXALINE, BENZOTRIAZOLE, DIHYDRO-IMIDAZO[4,5-c] PYRIDINONE AND DIHYDRO-ISOINDOLONE DERIVATIVES
10/09/2008US20080249099 7-Phenylalkyl Substituted 2-Quinolinones and 2-Quinoxalinones as Poly(Adp-Ribose) Polymerase Inhibitors
10/09/2008US20080249071 inhibitory activity against the activation of inflammatory cytokines such as interleukin (IL)-1, IL-6, IL-8 and tumor necrosis factor (TNF- alpha ), NF- kappa K B; inflammatory disorders, autoimmune diseases; side effects reduction; immuno suressants; N-[3,5-bis(trifluoromethyl)phenyl]-2-hydroxybenzamide
10/09/2008US20080248537 Biocatalytic asymmetric reduction in preparation of (s)-n-[5-(1,2-dihydroxy-ethyl)-pyrazinyl]-2,2-dimethyl-propionamide
10/09/2008US20080248093 pH sensitive prodrugs of 2,6-diisopropylphenol
10/08/2008EP1976840A1 Cyclohexyl piperazinyl methanone derivatives and their use as histamine h3 receptor modulators
10/08/2008CN101282948A Phosphatidylinositol 3-kinase inhibitors and methods of their use
10/08/2008CN101282947A Optical crystal films, based on acenaphthoquinoxaline sulfonamide derivatives having an acid substituent
10/08/2008CN101282946A 新的半胱氨酸蛋白酶抑制剂及它们的治疗应用 The new cysteine ​​protease inhibitors and their therapeutic applications
10/08/2008CN100424080C Quinoxaline derivatives as neutrophil elastase inhibitors and their use
10/07/2008US7432392 Ester derivatives and medical use thereof
10/07/2008US7432289 5-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors
10/07/2008US7432287 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance
10/07/2008US7432271 Atherosclerosis; anticholesterol agents; cardiovascular disorders; stroke; thrombosis; hypotensive agents; restenosis; antidiabetic agents; antiarthritic agents; anticancer agnets; inflammatory bowel disorders
10/07/2008US7432268 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
10/07/2008US7432264 Antibacterial compounds such as (S)-2-cyano-1-(trans-4-(5-nitro-2-pyridylamino)cyclohexylamino )acetylpyrrolidine; activity against Gram-negative and Gram-positive pathogens, including a methicillin-resistant S. aureus strain
10/07/2008CA2241933C Process for preparing alkoxypyrazine derivatives
10/02/2008WO2008117796A1 Novel mutilin derivatives
10/02/2008WO2008093024A3 N-(amino-heteroaryl)-1h-pyrrolopyridine-2-carboxamides derivatives, preparation thereof and their use in therapy
10/02/2008WO2008015429A3 Pharmaceutical compounds
10/02/2008US20080242666 e.g. (3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-6-(1-ethylpropyl)-1-[2(hydroxymethyl)benzyl]-piperazine-2,5-dione; preparation by cyclization
10/02/2008US20080242662 substituted 3,4- or higher substituted piperazine compounds; renin inhibitor; antidiabetic, analgesic,hypotensive agent; neurodegenerative diseases; preparation by reacting a carbonic acid with amino compound
10/02/2008US20080241955 Isobaric sets, mass differential labeling sets; mass spectrometry
10/01/2008EP1372655B1 Cathepsin cysteine protease inhibitors
10/01/2008CN101274945A Organometallic complex, and light-emitting element, light-emitting device and electronic device including the organometallic complex
10/01/2008CN100422147C Method of preparing compound of 0-substituted sulphonyl propylhomoserin class
09/2008
09/30/2008US7429666 Pyridine analogs as C5a antagonists
09/30/2008US7429585 Phenyl-piperazine methanone derivatives, substituted by heterocyclic groups
09/30/2008CA2355470C Benzoheterocycles and their use as mek inhibitors
09/25/2008US20080234301 Alpha-4 Integrin Mediated Cell Adhesion Inhibitors for the Treatment or Prevention of Inflammatory Diseases
09/25/2008US20080234289 Melanocortin Receptor-Specific Compounds
1 ... 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 ... 187